Publications

Publications

 

For each publication, click on the title for more information, including the abstract, complete citation, and access to the article. You will be redirected to the National Library of Medicine.

 

 

PubMed

Prion biology: implications for Alzheimer's disease therapeutics
Carlo Condello
Expanding spectrum of prion diseases.
Ayers JI
Paras NA
Prusiner SB
Expanding spectrum of prion diseases
Jacob I Ayers
Prion protein - mediator of toxicity in multiple proteinopathies.
Ayers JI
Prusiner SB
Prion protein - mediator of toxicity in multiple proteinopathies
Jacob I Ayers
Discovery of 4-Piperazine Isoquinoline Derivatives as Potent and Brain-Permeable Tau Prion Inhibitors with CDK8 Activity.
Grandjean JM
Jiu AY
West JW
Aoyagi A
Droege DG
Elepano M
Hirasawa M
Hirouchi M
Murakami R
Lee J
Sasaki K
Hirano S
Ohyama T
Tang BC
Vaz RJ
Inoue M
Olson SH
Prusiner SB
Conrad J
Paras NA
Discovery of 4-Piperazine Isoquinoline Derivatives as Potent and Brain-Permeable Tau Prion Inhibitors with CDK8 Activity
Jean-Marc M Grandjean
Kinetics of α-synuclein prions preceding neuropathological inclusions in multiple system atrophy.
Woerman AL
Patel S
Kazmi SA
Oehler A
Lee J
Mordes DA
Olson SH
Prusiner SB
Replication of multiple system atrophy prions in primary astrocyte cultures from transgenic mice expressing human α-synuclein.
Krejciova Z
Carlson GA
Giles K
Prusiner SB
Aβ and tau prion-like activities decline with longevity in the Alzheimer's disease human brain.
Aoyagi A
Condello C
Stöhr J
Yue W
Rivera BM
Lee JC
Woerman AL
Halliday G
van Duinen S
Ingelsson M
Lannfelt L
Graff C
Bird TD
Keene CD
Seeley WW
DeGrado WF
Prusiner SB
Multiple system atrophy prions retain strain specificity after serial propagation in two different Tg(SNCA*A53T) mouse lines.
Woerman AL
Oehler A
Kazmi SA
Lee J
Halliday GM
Middleton LT
Gentleman SM
Mordes DA
Spina S
Grinberg LT
Olson SH
Prusiner SB
A long-lived aβ oligomer resistant to fibrillization.
Nick M
Wu Y
Schmidt NW
Prusiner SB
Stöhr J
DeGrado WF